Literature DB >> 8228990

Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain.

S D Yang1, J S Song, J S Yu, S G Shiah.   

Abstract

Previously, we identified protein kinase FA/glycogen synthase kinase-3 (GSK-3) as a microtubule-associated protein tau kinase that can incorporate 4 mol of phosphates into 1 mol of tau protein and cause its electrophoretic mobility shift in sodium dodecyl sulfate gels, a unique property characteristic of paired helical filament-associated pathological tau (PHF-tau) in Alzheimer's disease brains. In this report, we identified TPPKS(p)PSAAK and SPVVSGDTS(p)PR as two phosphorylation site sequences phosphorylated by kinase FA/GSK-3 in tau using peptide sequence analysis and sequential manual Edman degradation for radiosequencing. When mapping with human brain tau sequence, we further identified Ser235-Pro and Ser404-Pro as the two major phosphorylation sites according to the numbering of the longest tau isoform. Ser235 and Ser404 have been reported as two of the major abnormal phosphorylation sites in PHF-tau. Taken together, the results provide initial evidence that protein kinase FA/GSK-3 may represent one of the Ser-Pro motif-directed tau kinases involved in the abnormal phosphorylation of pathological PHF-tau in Alzheimer's disease brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228990     DOI: 10.1111/j.1471-4159.1993.tb09811.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  MMFPh: a maximal motif finder for phosphoproteomics datasets.

Authors:  Tuobin Wang; Arminja N Kettenbach; Scott A Gerber; Chris Bailey-Kellogg
Journal:  Bioinformatics       Date:  2012-04-23       Impact factor: 6.937

2.  Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain.

Authors:  T J Singh; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  Mol Cell Biochem       Date:  1996-01-26       Impact factor: 3.396

3.  Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.

Authors:  A Sengupta; Q Wu; I Grundke-Iqbal; K Iqbal; T J Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

4.  Protein kinase C and calcium/calmodulin-dependent protein kinase II phosphorylate three-repeat and four-repeat tau isoforms at different rates.

Authors:  T J Singh; I Grundke-Iqbal; W Q Wu; V Chauhan; M Novak; E Kontzekova; K Iqbal
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

5.  Effect of GSK-3 overactivation on neurofilament phosphorylation.

Authors:  Juan Chen; Jie Zhou; Youmei Feng; Jianzhi Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

6.  Structural characterization of monoclonal antibodies targeting C-terminal Ser404 region of phosphorylated tau protein.

Authors:  Jessica E Chukwu; Erin E Congdon; Einar M Sigurdsson; Xiang-Peng Kong
Journal:  MAbs       Date:  2019-02-26       Impact factor: 5.857

7.  What Are the bona fide GSK3 Substrates?

Authors:  Calum Sutherland
Journal:  Int J Alzheimers Dis       Date:  2011-05-18

8.  Dissecting the M phase-specific phosphorylation of serine-proline or threonine-proline motifs.

Authors:  Chuan Fen Wu; Ruoning Wang; Qianjin Liang; Jianjiao Liang; Wenke Li; Sung Yun Jung; Jun Qin; Sue-Hwa Lin; Jian Kuang
Journal:  Mol Biol Cell       Date:  2010-03-10       Impact factor: 4.138

9.  Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain.

Authors:  J S Song; S D Yang
Journal:  J Protein Chem       Date:  1995-02

10.  GSK-3: Functional Insights from Cell Biology and Animal Models.

Authors:  Oksana Kaidanovich-Beilin; James Robert Woodgett
Journal:  Front Mol Neurosci       Date:  2011-11-16       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.